Aman's Global Market Intelligence

Executive dashboard

S&P 500 · Fri7,674.37+0.43%

Nasdaq · Fri26,180.46+0.43%

Dow · Fri53,277.01+0.98%

Russell 2000 · Fri3,017.87+0.85%

VIX · Fri15.13−5.50%

U.S. 2Y / 10Y · Fri4.24% / 4.74%+5 bp / +5 bp d/d

Dollar index · Fri98.80−0.10%

WTI futures · Fri$87.06−0.88%

Gold futures · Fri$4,680.60+3.64%

Nikkei · Fri66,016.36−0.30%

Hang Seng / Shanghai26,009 / 3,905+1.21% / +0.04%

Euro Stoxx 50 · Fri6,462.22+0.63%

DAX / FTSE · Fri26,136.56 / 10,816.60+0.59% / +0.64%

Weekend U.S. futuresClosedno actionable quote

1 · Trade

Canada escalation is the new gap risk

CNBC reports new 50% U.S. tariffs on some Canadian exports after talks failed; Canada says retaliatory tariffs begin Sept. 8. Monday's sector impact depends on the covered goods and any last-minute policy change. Weekend report

2 · AI

NVIDIA may pass through memory costs

CNBC, citing Bloomberg, says some large customers were warned of price increases of at least 15% on Vera Rubin/Grace Blackwell server systems shipped next year. ASP/margin support is plausible, but demand elasticity and customer capex response are unknown. CNBC

3 · Rates

Equities bounced; the curve did not

Official Treasury data put Friday's 2Y at 4.24%, 10Y at 4.74% and 30Y at 5.27%, each above Thursday. That leaves expensive duration themes exposed to Wednesday's GDP/PCE data even with VIX at 15.13. Treasury curve

Market drivers & Sunday outlook

Macro, central banks and geopolitics

Wednesday collision: BEA schedules Q2 GDP second estimate and July personal income/outlays for Aug. 26 at 08:30 ET (14:30 CEST). Growth and PCE components can move yields before NVIDIA reports. BEA schedule
No Fed meeting this week: the next FOMC is Sep. 15–16 and includes projections. Near-term policy repricing therefore runs through data and Fed communication. Fed calendar
Trade shock: the U.S.–Canada breakdown adds inflation, margin and retaliation uncertainty. Do not infer a broad index outcome until contract coverage and Monday sector breadth are visible. CNBC
Iran: tougher proposed U.S. sanctions keep energy and geopolitical premia live. Gold's Friday surge and WTI near $87 are risk signals, not proof of imminent military escalation. CNBC

Earnings, rotation and verified moves

Friday breadth improved: Dow and Russell outperformed the S&P while VIX fell. Yet NVDA (−0.98%), VRT (−1.01%) and MU (−0.77%) lagged; ANET (+2.67%) and AVGO (+1.21%) showed selective infrastructure strength. S&P · NVDA
NVIDIA is the week's fulcrum: earnings are expected Wednesday after the U.S. close. Its latest SEC filing is an Aug. 17 8-K; weekend pricing reports are secondary-source information, not company guidance. SEC 8-K · IR events
Robotics appetite is elevated: Unitree reportedly rose 542% on its Shanghai debut. This is evidence of speculative demand for robotics, not a valuation read-through for U.S.-listed automation suppliers. CNBC
Biotech breadth: XBI rose 1.44%, but AMLX fell 2.52% following its recent financing. Clinical evidence improved; dilution and regulatory execution remain separate risks. XBI · Amylyx news

Theme dashboards

AI · selective

Pricing power meets demand elasticity

Leaders/laggards Friday: ANET +2.67% and AVGO +1.21% led; NVDA −0.98%, VRT −1.01%, MU −0.77% and AMZN −0.57% lagged.
New catalyst: reported NVIDIA server price increases above 15% may offset memory inflation, but the report concerns systems shipping next year and does not quantify orders, margins or cancellations. source
Risk: a 4.74% 10Y, customer financing, export controls, power availability and capex concentration can dominate even strong end demand.

Quantum · speculative

Momentum still outruns economics

Friday surge: RGTI +11.48%, QUBT +9.58%, QBTS +8.46% and IONQ +8.02% on high volume.
Primary check: D-Wave filed an Aug. 18 8-K tied to a DOCOMO deployment; economics remain undisclosed. No newer material filing was found for RGTI or IONQ in SEC submissions through this cutoff. QBTS 8-K
Risk: small/high-beta names face dilution, architecture, commercialization and squeeze risk. No borrow availability or fee is implied.

Peptide biotech

Strong topline, incomplete de-risking

AMLX: company-reported Phase 3 LUCIDITY data in 78 participants showed a 55% reduction in composite Level 2/3 hypoglycemic events versus placebo (p=0.000003), all secondary endpoints met and no treatment-related serious AEs; NDA submission is planned by year-end. company topline
Registry caveat: ClinicalTrials.gov still lists NCT06747468 active-not-recruiting with 75 estimated enrollment and October estimated completion, showing a lag versus the company's topline. registry
Retatrutide: the 1,152-participant Phase 3 T2D/obesity study is listed completed June 16; completion alone does not establish efficacy or safety. registry

Ranked ideas — conditional, Monday confirmation required

1Conditional bullish

AVGO · Broadcom (Nasdaq)

Risk class: large-cap, high-duration AI/custom silicon · Classification: confirmed watch-to-long candidate · Horizons: day trade only on Monday follow-through; 1–4 week swing into Sep. 2; 3–12+ month only after earnings. Direction remains uncertain across events.

Thesis/catalyst: Friday closed $368.45 (+1.21%), above the pre-stated $368 confirmation while NVDA/MU fell. NVIDIA Wednesday and Broadcom Sep. 2 can validate networking/custom-silicon demand.

Evidence / counterargument: relative strength and a confirmed close support the setup. Counter: rejection from $375.13, 10Y at 4.74%, customer concentration, integration/leverage and earnings-gap risk.

Entry/confirmation: hold $365–368 and reclaim $372; avoid chasing a tariff-driven gap. Invalidation/downside: close below $355; next risk near $345. Key risks: estimates, AI capex, margins, rates and concentration. quote

Thesis Confidence 69

Risk 77

Opportunity 65

1Avoid pre-earnings chase

NVDA · NVIDIA (Nasdaq)

Risk class: mega-cap, high-duration / binary earnings gap · Classification: avoid new pre-event swing; tactical bearish only on confirmation · Horizons: day trade Monday–Wednesday; 1–4 weeks only after results; 3–12+ month thesis remains constructive but entry is valuation-dependent.

Thesis/catalyst: $214.72 Friday, −0.98% against Nasdaq +0.43%, below last week's failed long threshold. Reported >15% system price increases may support ASP but also test customer elasticity.

Evidence / counterargument: weak relative strength and rising yields favor caution. Counter: pricing power, profitable scale and a strong earnings guide can gap through resistance.

Entry/confirmation: bearish only below $214.50 with weak semis; do not carry a tactical short through earnings. Invalidation/downside: reclaim $219–220; bearish references $210 then $200. Short loss is unlimited; no borrow claim. quote

Thesis Confidence 75

Risk 93

Opportunity 55

2Avoid momentum chase

RGTI / QBTS / IONQ / QUBT · quantum basket

Risk class: small/high-beta speculative growth; dilution and squeeze prone · Classification: avoid chase, not an active basket short · Horizons: day trade only; 1–4 week observation; no 3–12+ month entry without commercial evidence. Direction uncertain.

Thesis/catalyst: Friday gains of 8%–11% without newly verified economic disclosure create weak chase asymmetry under a 4.74% 10Y.

Evidence / counterargument: breadth and volume are strong. Counter: momentum can persist violently and deployments can create real option value.

Entry/confirmation: no Sunday/Monday blind short; consider bearish exposure only after failed Friday-high retests and Friday-low breaks: RGTI $16.30, QBTS $19.10, IONQ $42.01, QUBT $8.24. Invalidation: closes above Friday highs. Short losses unlimited; no borrow claim.

Thesis Confidence 67

Risk 95

Opportunity 47

No second compelling bullish idea: weekend trade risk, elevated long yields and Wednesday's concentrated macro/NVIDIA events make fresh risk/reward unattractive before confirmation.

Watchlist — maximum five

Ticker / risk class	Classification & separately applicable horizon	Thesis, catalyst & evidence / counterargument	Entry / invalidation / downside / risks	C / R / O
Watch ANET NYSE · liquid AI networking growth	Relative-strength watch. Day: Friday-high break. Swing 1–4 weeks: close above $190.44. Long term: wait for valuation/FCF update. Direction uncertain.	+2.67% Friday led tracked AI infrastructure. NVIDIA can validate networking demand. Counter: event concentration, high-duration valuation and customer concentration.	Confirm >$190.44 with breadth; invalidate <$183.59, downside reference $180. Rates, capex and competition.	68 / 76 / 64
Watch MU Nasdaq · liquid cyclical AI memory	Rebuild watch. Day: above $990. Swing: close above $1,000. Long term: wait for cycle/valuation update.	Reported NVIDIA price hikes cite memory costs, supporting memory pricing logic. Counter: MU fell 0.77% and remains cyclically exposed.	Confirm close >$1,000; invalidate <$958, harder stop <$930. Supply, pricing, capex and geopolitical risks.	69 / 80 / 63
Watch XBI NYSE Arca · diversified high-volatility biotech ETF	Stabilization. Day: $168 break. Swing: close above $168. Long term: diversified sleeve only.	+1.44% to $165.73; less binary than AMLX. Counter: failed to close above $166–168 and funding costs remain high.	Confirm >$167.91; invalidate <$163.74 then $160. Clinical, FDA, pricing and financing risks.	65 / 70 / 60
Watch AMLX Nasdaq · small/mid-cap biotech; binary/dilution sensitive	Post-offering base watch. Day/swing only after base; 3–12 months speculative after NDA path. Direction uncertain.	Phase 3 endpoint/statistics and reported safety support avexitide. Counter: regulatory review, label, manufacturing, competition and dilution remain unresolved.	Confirm close >$41.14 then $42; invalidate <$38.35, major downside $35.50. Binary gaps and financing. Not penny/OTC.	82 / 92 / 59
Watch AMZN Nasdaq · mega-cap cloud/platform, capex intensive	Repair watch. Day: $261 reclaim. Swing: close >$264. Long term: only with FCF/capex visibility.	AWS is structural AI exposure. Counter: −0.57% Friday, tariff sensitivity through retail and high AI capex.	Confirm $261 then $264; invalidate <$257.04, downside $250. Rates, capex, trade, consumer and regulation.	64 / 75 / 56

C / R / O = Thesis Confidence / Risk / Opportunity. Confidence measures evidence quality, not outcome probability.

Changes versus the 2026-08-22 report

Regime unchanged: neutral/cautious. Friday breadth remains constructive, but no tradable Sunday futures exist to confirm or reject the new trade/geopolitical information.
New NVIDIA information: reported server price increases above 15% add potential pricing power and margin support, but also demand-elasticity risk. This does not reverse the pre-earnings avoid stance.
New macro gap risk: the failed U.S.–Canada negotiations and new/retaliatory tariffs are added to Monday's checklist; trade-exposed sectors require live breadth confirmation.
AI watchlist rotation: ANET enters after Friday's +2.67% relative strength; WMT leaves the maximum-five list, though its post-earnings stabilization remains unresolved.
No hindsight changes: AVGO remains the only conditional bullish setup; quantum remains avoid-chase despite Friday's rally; AMLX remains a base watch, not a retroactive long.

Important catalysts: next 7–30 days

Aug. 24 · Monday — first tradable reaction
Watch U.S.–Canada tariff sectors, oil/gold, the 10Y, semis and whether AVGO/ANET relative strength survives. Weekend headlines can gap Europe before Wall Street. trade report

Aug. 26 · 14:30 CEST — U.S. GDP second estimate + July income/outlays
Simultaneous growth and PCE information can move the curve, dollar and duration equities. BEA

Aug. 26 · after U.S. close — NVIDIA FY27 Q2 expected
Central compute/networking/memory/power/cooling read-through. Watch revenue, gross margin, supply, customer financing, reported system pricing and export controls. NVIDIA IR · latest 8-K

Aug. 28 · BLS preliminary payroll benchmark expected
Potential labor-history revision, separate from monthly payrolls. BLS blocked this run; date is carried from the prior report and requires re-verification before trading. BLS schedule

Sep. 2 — Broadcom Q3 earnings expected
Custom silicon/networking, customer concentration, integration and AI financing are central for the carried bullish setup. Broadcom IR

Sep. 3–4 — U.S. trade and August employment
BEA confirms trade on Sep. 3; payrolls are the key rate-sensitive event. BEA · BLS

Sep. 8 — Canadian retaliatory tariffs announced to begin
Scope, exemptions and negotiations can change before implementation; reassess rather than assume. CNBC

Sep. 15–16 — FOMC meeting + projections
Official calendar confirms a projection-bearing meeting. Fed

By year-end — AMLX planned avexitide NDA
Not a dated FDA decision. Regulatory acceptance, review timing, manufacturing and label remain open. company

Bottom line by horizon

Day trade

Bias: neutral until Monday bonds and breadth agree. AVGO is constructive only above $372 after holding $365–368; ANET needs $190.44; avoid chasing quantum or a tariff gap.

Biggest risk: weekend trade/geopolitical gap. Invalidation: broad weakness with 10Y above 4.75% shifts risk-off; positive breadth with 10Y below 4.67% improves risk appetite.

1–4 week swing

Bias: keep size light into Wednesday. Prefer post-event confirmation; AVGO is the sole pre-event conditional long.

Biggest risk: GDP/PCE and NVIDIA jointly reprice rates and AI capex. Invalidation: S&P above 7,700 with 10Y below 4.67% improves the stance; below 7,660 with rising yields worsens it.

3–12+ month investment

Bias: profitable AI infrastructure remains preferable to quantum pure plays or single-asset biotech; demand cash-flow and valuation evidence. Keep quantum/biotech to risk-budgeted speculative sleeves.

Biggest risk: peak expectations plus high discount rates. Invalidation: durable FCF acceleration, lower long yields or regulatory/clinical progress that materially improves probability-adjusted cash flow.

Data quality & methodology

Timestamp/session: generated Sunday 08:34:38 CEST. Cash markets and Yahoo chart observations are Aug. 21 closes; CNBC's world dashboard independently matched key Asian closes. U.S. Sunday futures had not opened at cutoff.
Primary/live retrievals: Yahoo chart API for 32 indices/assets/theme names; official Treasury XML; SEC company submissions and filings for NVIDIA, AMLX, RGTI, QBTS and IONQ; NVIDIA IR; Federal Reserve calendar; BEA schedule; ClinicalTrials.gov API; Amylyx release. News was cross-checked through CNBC pages and Google News RSS carrying Reuters/Bloomberg-attributed headlines.
Price-vendor difference: Yahoo showed WTI $87.06 and gold $4,680.60, versus the prior CNBC dashboard's $86.64/$4,661.60 fields. This report uses one consistent Yahoo Friday settlement/last series and identifies the source/session; commodity contracts and timestamps can differ.
Limitations: Yahoo's multi-quote endpoint returned HTTP 401, so individual chart endpoints were used successfully. Web extraction for Fed/Treasury/SEC failed for insufficient service credits, so direct official HTTP endpoints were used. BLS returned HTTP 403; the Aug. 28 catalyst is carried from the prior report and explicitly unverified today. Broadcom IR timed out twice; its date is labeled expected and the link is supplied for recheck.
No unavailable market-data claim: the individual Yahoo chart API, CNBC dashboard and official Treasury feed succeeded, so dashboard fields are available. Weekend U.S. futures are marked closed, not unavailable.
Scoring: Thesis Confidence reflects evidence quality, not guaranteed probability. Risk rises with uncertainty, leverage, liquidity, valuation, dilution and binary exposure. Opportunity balances evidence, asymmetry and timing. Levels are paper-tracking triggers, not orders.

Aman's Global Market Intelligence — 2026-08-23